← Leaderboards
Lyndsay Norine Harris
Dana-Farber Cancer Inst
$1,025,827
Attributed
$1,612,122
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $725.9K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,612,122 · 2
By mechanism
R01$1,172,590 · 1
P50$439,532 · 1
Top collaborators
- David L Rimm2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Donald W. Kufe$50,160,456
- Michael J Eck$25,871,961
- Daphne A. Haas-Kogan$5,585,485
- Geoffrey I Shapiro$18,639,470
- Laurie H Glimcher$56,303,115
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseTumorChemotherapyCancer PatientTrastuzumabErbb2 GeneSignal PathwayPharmaceutical PreparationsPathway InteractionsMalignant NeoplasmsMutationMammary NeoplasmsBaseNeoplastic CellGrowth FactorFamily MemberInhibitor/AntagonistCarcinogenesisCci-779BreastAntibodiesCombined Modality TherapyEarly DiagnosisAnalog
Grant awards (6)
Optimal Predictors of Response to Trastuzumab$584,668
R01 · FY2010 · CA
Optimal Predictors of Response to Trastuzumab$587,922
R01 · FY2009 · CA
Targeted Combinations for Her2- Positive Breast Cancer Biology$137,947
P50 · FY2009 · CA · contact PI
Targeted Combinations for Her2- Positive Breast Cancer Biology$80,804
P50 · FY2008 · CA · contact PI
P-2: Target Combinations for HER2 - Positive Breast Cancer$133,233
P50 · FY2007 · CA · contact PI
P-2: Target Combinations for HER2 - Positive Breast Cancer$87,548
P50 · FY2006 · CA · contact PI